Two complement inhibitors tied to increased risk of wet AMD, but data called suspect ...

Please provide your email address to receive an email when new articles are posted on . For the fourth consecutive year, Prevent Blindness has declared Dec. 2 to 8 as Geographic Atrophy Awareness Week ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In 2024, Healio covered several stories about trials ...

A novel outcome measure for geographic atrophy, the Geographic Atrophy Weighted-by-Acuity Index, aligned with best-corrected visual acuity, showing better correlation and predictive accuracy than the ...

Ryan Haumschild, PharmD, MS, MBA, opens a discussion surrounding the disease landscape of geographic atrophy. Ryan Haumschild, PharmD, MS, MBA: Hello, and welcome to this AJMC® Peer Exchange®program ...

What is IZERVAY™?IZERVAY (avacincaptad pegol intravitreal solution) is a prescription eye injection, used to treat geographic atrophy (GA), the advanced form of dry age-related macular degeneration ...

A real-world analysis suggests complement inhibitors for geographic atrophy may raise risks of exudative age-related macular degeneration, subfoveal GA progression, and vision loss, with statistical ...

Geographic atrophy (GA) is an advanced form of dry macular degeneration that causes irreversible vision loss and affects daily activities such as reading, driving, and recognizing faces. Vision loss ...

I’m 79 now, and my doctor diagnosed me with age-related macular degeneration (AMD) in 2008. Over the past 15 years, I’ve developed wet AMD in my left eye and geographic atrophy (GA) in both eyes. I ...

Randomized trials of two FDA-approved intravitreal complement inhibitor injections showed that they slowed the progression of geographic atrophy, but failed to demonstrate functional benefits at 24 ...

ACP is an investigational complement C5 inhibitor that is designed to decrease the activation of inflammasomes and the formation of membrane attack complex. The Food and Drug Administration (FDA) has ...

The US Food and Drug Administration (FDA) has approved pegcetacoplan injection (Syfovre) as the first treatment for geographic atrophy (GA), a major cause of adult blindness. "The approval of SYFOVRE ...